United Therapeutics completed facility construction in Minnesota and Texas and submitted an NDA to the FDA.
3 reports, 3 independent
Updated 00:00
Still developing
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
United Therapeutics completed facility construction in Minnesota and Texas and submitted an NDA to the FDA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.UT is building a hangar near Rochester airport and has a facility in Stewartville.1 source
UT is opening a new Houston facility and awaiting FDA clearance for its products.1 source
UT completed construction in MN/TX and submitted an NDA to the FDA.1 source
Keep exploring
The entities involved
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States
- Cantor Fitzgerald restated an overweight rating and Royal Bank of Canada reduced its price objective for United Therapeutics.
- Various financial institutions, including Royal Bank of Canada, Bank of America, Raymond James Financial, TD Cowen, Cantor Fitzgerald, and MarketBeat, issued rating and price target updates regarding United Therapeutics on July 10, 2026.
- FDA
Related events
- A facility located in St. George is operating under the standards set by the U.S. Food and Drug Administration (FDA) for supplement manufacturing.
- FDA approval supports NDA submission in Aurora.
- A network focused on cell and gene therapies is expanding to include sites in Northern California, involving the CA Institute for Regenerative Medicine and the FDA.
- FDA and state authorities are investigating product manufacturers in Utah.